Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
1997 | 44 | 4 |
Tytuł artykułu

2-methyl-thiazolidine-2,4-dicarboxylic acid protects against paracetamol induced toxicity in human liver derived HepG2 cells

Warianty tytułu
Języki publikacji
The effects of 2-methyl-thiazolidine-2,4-dicarboxylic acid (CP) on paracetamol-induced toxicity were investigated and evaluated in a human liver derived HepG2 cell line. Incubation of the cells with CP (2 mM and 10 mM) drastically attenuated the GSH and cysteine depletion caused by toxic concentrations of paracetamol (1 mM and 5 mM). When CP (10 mM) was introduced alone into the medium, the level of malondialdehyde and the reactive oxygen species were maintained at the control levels with a simultaneous increase of non-protein sulfhydryl in the cells. Thus, the results of our work prove that CP is a non-toxic precursor of cysteine and GSH, and successfully prevents paracetamol toxicity in HepG2 cells.
Opis fizyczny
  • Collegium Medicum, Jagiellonian University, M.Kopernika 7, 31-034 Cracow, Poland
  • 1. Dahlin, D.C., Miwa, G.T., Lu, A.H. & Nelson, S.D. (1984) iV-Acetyl-p-benzoquinone imine: A cytochrome P-450-mediated oxidation prod­uct of acetaminophen. Proc. Natl. Acad. Sci., U.S.A. 81, 1327-1331.
  • 2. Wendel, A. & Keuerstcin, S. (1981) Drug in­duced lipid peroxidation. I. Modulation by monooxygenase activity, glutathione and se­lenium salts, Biochem. Pharmacol. 30, 2513- 2520.
  • 3. Mitchel, J R., Jollow, D.J., Potter, W.Z., Gil­lette, J.R. & Brodie, B.B. (1973) Acetamino- phen-induced hepatic necrosis IV, Protective role of glutathione. J. Pharmacol. Exp. Ther. 187, 211-217.
  • 4. Reed, D.J. (1990) Glutathione: Toxicological implications. Annu. Rev. Pharmacol. Toxicol. 30, 603-631.
  • 5. Tate, S.S. (1980) Enzymes of mercapturic acid formation; in. Enzymatic Basic of Detoxica- tion (Jacoby, W.B., ed.) vol. 2, pp. 95-120, Academic Press, New York.
  • 6. Holme, J.A., Dahlin, D.C., Nelson, S.D. & Dybing,E. (1984) Cytotoxic effects of AT-acetyl- p-benzoquinone imine, a common arylating intermediate of paracetamol and N-hydroxy- paracetamol. Biochem. Pharmacol. 33, 401- 406.
  • 7. Meister, A. & Anderson, M.E. (1983) Glu­tathione. Ann«. Rev. Biochem. 52, 711-760.
  • 8. Puka-Sundvall, M., Eriksson, P., Nilsson. M., Sandberg. M. & tahmann, A. (1995) Neuro­toxicity of cysteine: Interaction with gluta­mate. Brain Res. 705. 65-70.
  • 9. Hahn, R., Wendel, A. & Flohe, L. (1978) The fate of extracellular glutathione in rat. Bio- chim. Biophys. Acta 529, 324-337.
  • 10. Wlodek, L. & Rommelspacher. H. (1994) Ethanol-induced changes in the content of thiol compounds and of lipid peroxidation in livers and brains from mice: Protection by thiazolidine derivatives. Alcohol and Alcohol­ism 29, 649-651.
  • 11. Włodek, L., Rommelspacher, H. (1997) 2- Methyl-thiazolidine-2,4-dicarboxylic acid as prodrug of L-cysteine. Protection against paracetamol hepatotoxicity in mice. Fundam. Clin. Pharmacol. 11,454-459.
  • 12. Smilkstein, M.J., Knapp, G.L., Kulig, K.W. & Rumack, M.D. (1988) Efficacy of oral //-ace­tylcysteine in the treatment of acetamino­phen overdose. N. Engl. J. Med. 318, 1557-1562.
  • 13. Estrela, J.M., Saes. G.T., Such, L. & Vina, J. (1983) The effect of cysteine and ^-acetylcys­teine on rat liver glutathione (GSH). Biochem. Pharmacol. 324, 3483-3485.
  • 14. Doostdar, H., Duthie, S.J., Burke, M.D., Melvin, W.T. & Grant M.H. (1988) The influ­ence of culture medium composition on drug metabolising enzyme activities of the human liver derived HepG2 cell line. FEBS Lett. 241, 15- 18.
  • 15. Schubert, M.P. (1936) Compounds of thiol acids with aldehydes. J. Biol. Chem. 114, 341-350.
  • 16. Visvikis, A., Goergen, J.I,., Oster, T., Bargel, D., Wellman, M., Marc, A, Engasser, J.M. & Srest, G. (1990) Gamma-glutamyltransferase from human hepatoma cell lines: Purification and cell culture of HepG2 on microcarriers. Clin. Chim. Acta 191, 221-232.
  • 17. Tietze, F. (1969) Enzymatic method for quan­titative determination of nanogram amounts of total and oxidized glutathione: Application to mammalian blood and other tissues. Anal. Biochem. 27, 502-522.
  • 18. Gaitonde, M.K. (1967) A spectrophotometry method for the direct determination of cyste­ine in the presence of other naturally occur­ring amino acids. Biochem. J. 104, 627-633.
  • 19. Moron, M.S., Depierre, J.W. & Mannervik, B. (1979) Levels of glutathione, glutathione re­ductase and glutathione-S-transferase activi­ties in rat lung and liver. Biochem. Biophys. Acta 67, 582-589.
  • 20. Ohkawa, H., Ohishi, N. & Jagi, K. (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95, 351-358.
  • 21. Bondy, S.C. & Guo, S.X. (1994) Effect of ethanol treatment on indices of cumulative oxidative stress. Eur. J. Pharmacol. Environ. Toxicol. Pharmacol. Section 270, 349-355.
  • 22. Bulera, S.J., Birge, R.B., Cohen, S.D. & Khai- rallah, E.A. (1995) Identification of the mouse liver 44-kDa acetaminophen-binding protein as a subunit of glutamine synthetase. Toxi­col. Appl. Pharmacol. 134, 313-320.
  • 23. McLean, A.E.M., Armstrong, G.R. & Beales, D. (1989) Effect of D- or ^methionine and cysteine on the growth inhibitory effects of feeding 1% paracetamol to rats. Biochem. Pharmacol. 38, 347-352.
  • 24. DalhoiT. K. & Poulsen, H.E. (1992) Effects of cysteine and acetaminophen on the syntheses of glutathione and adenosine 3'-phosphate S'-phosphosulfate in isolated rat hepatocytes. Biochem. Pharmacol. 44, 447-454.
  • 25. Dalhoff, K. & Poulsen, H.E. (1993) Synthesis rates of glutathione and activated sulphate (PAPS) and response to cysteine and acetami­nophen administration in glutathione-de- pletcd rat hcpatocytes. Biochem. Pharmacol. 46, 1295-1297.
  • 26. Lauterburg, B.H., Corcoran, G.B. & Mitchel J.P. (1983) Mechanism of action of AT-acetyl- cysteine in the protection against the hepato­toxicity of acetaminophen in rats in vivo. J. Clin. Invest. 71, 980-991.
  • 27. Lu, S.C. & Huang, H.Y. (1994) Comparison of sulfur amino acid utilization for GSH syn­thesis between HepG2 cells and cultured rat hepatocytes. Biochem. Pharmacol. 47, 859- 869.
  • 28. Duthie, S.J., Coleman, O.S. & Grant, M.H. (1988) Status of reduced gluthationc in the human hepatoma cell line HepG2. Biochem. Pharmacol. 37, 3365-3368.
  • 29. Richman, P.B. & Meister, A. (1975) Regula­tion of y-glutamyl-cysteine synthetase by non allosteric inhibitor by glutathione. J. Biol. Chem. 250, 1422-1426.
  • 30. Russo, A., DeGraf, W., Friedman, N. & Mitchell, J.B. (1986) Selective modulation of glutathione levels in human normal versus tumor cells and subsequent differential re­sponse to chemotherapy drugs. Cancer Res. 46, 2845-2848.
  • 31. Takamura, S., Joshida, «J. & Suzuki, S. (1991) Growth promoting action of 1,-cysteine and its related compounds on Ehrlich ascites tumor cells in vitro. Folia Pharmacol. Jpn. 98, 443-448.
  • 32. Vina, J., Romero, K.J., Saez, G.T. & Pallardo F.V. (1983) Effect of cysteine and JV-acetylcys- teine on GSH content of brain of adult rats. Experientia 39, 164-165.
  • 33. Baruchel, S.. Wang, T., Farah, R., Jamali, M. & Batist, G. (1995) In vivo selective modula­tion of tissue glutathione in rat mammary carcinoma model Biochem. Pharmacol. 50, 1505- 1508.
  • 34. Meister, A. (1991) Glutathione deficiency pro­duced by inhibition of its synthesis and its reversal applications in research and therapy. Pharm. Ther. 51, 155-194.
Typ dokumentu
Identyfikator YADDA
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.